ICS/formoterol in the management of asthma in the clinical practice of pulmonologists: an international survey on GINA strategy

BACKGROUND: The treatment with short-acting beta-2 agonists (SABA) alone is no longer recommended due to safety issues. Instead, the current Global Initiative for Asthma (GINA) Report recommends the use of the combination of inhaled corticosteroids (ICS) with the rapid/long-acting beta-2 agonist for...

Descripción completa

Detalles Bibliográficos
Autores principales: Cruz, Álvaro A., Barile, Sara, Nudo, Elena, Brogelli, Laura, Guller, Patricia, Papi, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844897/
https://www.ncbi.nlm.nih.gov/pubmed/33514439
http://dx.doi.org/10.1186/s40733-021-00067-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844897/
https://www.ncbi.nlm.nih.gov/pubmed/33514439
http://dx.doi.org/10.1186/s40733-021-00067-z

Ejemplares similares